Drug Shortage Report for NUCYNTA EXTENDED-RELEASE
Report ID | 25122 |
Drug Identification Number | 02415585 |
Brand name | NUCYNTA EXTENDED-RELEASE |
Common or Proper name | Nucynta |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | Tapentadol |
Strength(s) | 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 Tabs |
ATC code | N02AX |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-30 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-12-30 |
Shortage status | Resolved |
Updated date | 2018-05-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-05-17 | French | Compare |
v7 | 2018-05-17 | English | Compare |
v6 | 2018-05-17 | English | Compare |
v5 | 2017-12-31 | English | Compare |
v4 | 2017-12-06 | French | Compare |
v3 | 2017-12-06 | English | Compare |
v2 | 2017-10-10 | French | Compare |
v1 | 2017-10-10 | English | Compare |
Showing 1 to 8 of 8